Select Biotechnolgy PortFBIOX

13F holders, Q3 2024 (September 30)
1holders −1
0new positions
1sold out
$10.75avg. 13F price*

At the end of Q3 2024, 1 institutions reported holding Select Biotechnolgy Port (FBIOX) in their 13F filings, down 1 from Q2 2024. 0 opened new positions and 1 sold out. The largest holder was Coston, McIsaac & Partners ($1K).

Company
Select Biotechnolgy Port
Filed as
FIDELITY SELECT BIOTECHNOLOGY (Q3 2024)
CUSIP
316390772
Latest filing quarter
Q2 2026

History

Number of 13F holders

0123 Q1 2024: 1Q1 2024Q2 2024: 2Q2 2024Q3 2024: 1Q3 2024Q4 2024: 2Q4 2024Q1 2025: 3Q1 2025Q2 2025: 2Q2 2025Q3 2025: 2Q3 2025Q4 2025: 2Q4 2025Q1 2026: 3Q1 2026Q2 2026: 2Q2 2026

Total Exit/New Position Q2 2024 → Q3 2024

InstitutionsTotal Value
New Positions0$0
Exits1$44K

All 13F filers, Q2 2024 → Q3 2024: 5 shares bought and 2,254 shares sold, net −2,249 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.

Ownership 1 holders

Coston, McIsaac & Partners 0.00% Add +5.7% 93 $1K

"% of holder's portfolio" is FBIOX's weight in each manager's 13F, not the share of Select Biotechnolgy Port the manager owns.